Caris Life Sciences Inc — AI technical analysis, September 2026
NYSE/NASDAQ · Biotechnology
AI Recommendation
HOLD
Technical score 40/100
Last price: $24.82 · 52W range $14.19 – $35.20
Short answer
Should you buy CAI right now? Stockgaide's AI rates CAI as
HOLD, with a technical score of
40/100 at a last price of $24.82.
The 50-day average is below the 200-day average, and RSI sits at 66.6.
Wall Street's consensus rating is 1.88/5.
Full AI analysis for CAI
Strategic Conclusion
Recommendation: Hold
Why? The stock is trading above both its 50-day and 200-day moving averages, but the 50-day remains below the 200-day, signaling lingering medium-term pressure. Valuation is rich at 67x earnings, and while analysts lean bullish, the technical score is a sell due to bearish MACD momentum. This mix argues for patience rather than new buying or selling.
Ideal profile: Long-term investor willing to tolerate volatility; short-term traders should wait for clearer momentum confirmation.
Price range: Entry zone $21.00–$22.00 on a pullback; resistance at $26.50–$28.00; stop-loss below $20.00.
Practical action: Hold current positions. Add only on a pullback toward the SMA50 area ($20–$21) or on a confirmed daily close above $26.50 with MACD turning up.
1. Recent Price & Momentum
Current price $24.82 sits roughly in the middle of the 52-week range ($14.19–$35.20), about 29% below the high and 75% above the low.
The stock has recovered strongly from the lows but is not near the top; it is in a sideways-to-constructive phase.
Short-term scenario: likely to consolidate between $22 and $26 until MACD regains positive momentum; a break above $26.50 would open a move toward $28–$30.
2. Valuation (P/E)
P/E TTM of 67.39 is very expensive for most sectors, though not unusual for a growth-oriented life sciences company.
The market is pricing in significant future earnings growth; any disappointment in execution or guidance could trigger a sharp de-rating.
At this multiple, the stock already reflects optimistic expectations, leaving limited margin of safety.
3. Technical Analysis
SMA50 ($20.11) is below SMA200 ($20.95) — a bearish crossover, but price is above both, showing recent strength.
RSI at 66.6 is neutral, not overbought, leaving room for further upside but no strong momentum signal.
MACD (1.56) is above zero but below its signal line (1.85), with a negative histogram — momentum is fading.
Technical score: 40/100 → SELL, driven by the SMA structure and MACD divergence.
4. Analyst Consensus
Mean rating 1.88/5 with 12 buy, 4 hold, 0 sell — a strong bullish consensus.
This aligns with the price being above key moving averages but diverges from the technical sell signal.
The bullish analyst view may be justified by fundamentals, but the technical setup suggests waiting for a better entry rather than chasing here.
Technical signal details
Rule-based read from price and momentum indicators only — the score behind the AI's recommendation above. Technical score: 40/100 (SELL).
50-day moving average is below the 200-day — medium-term downtrend pressure.
MACD is below its signal line — bearish momentum.
RSI at 66.61 — neutral momentum.
Wall Street consensus rating of 1.88 — analysts lean Buy.
Stockgaide's AI currently rates CAI as HOLD, with a technical score of 40 out of 100 at a last price of $24.82. This is educational content, not investment advice.
Is CAI in an uptrend?
CAI's 50-day moving average (20.11) is below its 200-day moving average (20.95), which points to a medium-term downtrend.
What is CAI's RSI today?
CAI has a 14-day RSI of 66.6, which places it in neutral territory (above 70 is overbought, below 30 is oversold).
What do analysts say about CAI?
Wall Street analysts covering CAI have a consensus rating of 1.88 out of 5 (1 = Strong Buy), meaning they lean Buy — 12 Buy · 4 Hold · 0 Sell.
Where is CAI trading in its 52-week range?
CAI last traded at $24.82, against a 52-week range of $14.19 to $35.20 — about 51% of the way up that range.
Get the full AI analysis of CAI
Price targets, fundamentals deep-dive and an AI-written report — free, no signup.